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shown that bcs?iides interleukin-6 (IL-G), related cyrokines uch as leukcrnirc inhibitory factor, oncoatation M and interleukin-I t are also mediators 
c~‘c&z izrgdck accrCi.3qctase mqamic. tt_kWusc me&cars dcCongta t&e &e~~~~oqaicCc&rt~& a&&&!za~c~tatiu~. &GZ WU&QW ttkuar*xaXtit~J 
nmcrtiacr 0Nils cytddme?anilE. Ciilacv ncurotrqddIcTa~tor:C~‘i-:l.‘tn~~~css~lne’n~~it~c aclitc_dnase.or61~In~cnc.encinqnt~~Idcil~._o;,-an~l~n-~~~~~- 
sin, a+nncrogl&ulin and P-Abrinogon in human hepuomn cells (HcpG?.) and in primary rat hcpn~~ylcs with a time courx and dose-response 
comparable wilh that of IL-G. Our next aim was to define the receptor components used by CNTF on hepa~ic ells. Using a cell-free bindin& assay 
we exclude that CNTF binds to the 80 kDa IL-G rcceplor, a protein with sipnificnnt homology to the CNTF reccplor which has recently been cloned 
ffeom neuroWxstornti c&s. In human hqxtonw ce& .Ml;o3f?l which l;rck the leukemkt inhihitoxv ~factor_mto.q CWW xes .MJ aI& 50 in&x 
xutc-phase protein synthesis, indicating thar ihis receptor protein may bc part of the functional CNTF receptor on hepatic cells. 
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1. INTRODUCTION 
The response of higher organisms to disturbances of 
their homeostasis due to infection, tissue injury, neo- 
plastic growth, or irrmrrrmkrgic disorders is cakd the 
acute-phase response. It consists of an initial local reac- 
tion at the site of injury followed by a systemic reaction 
(for reviews see [l-3]). An important part of the sys- 
temic reaction is the stimulation of acute-phase protein 
synthesis in the liver [3]. IL-6 has been shown in the rat 
in vivo [4,5], in rat [6,7] and human [8] hepatocyte pri- 
mary cultures and in various hepatoma cell lines [6,9] 
to be the major mediator of acute-phase protein regula- 
tion. In recent years, additional cytokines with hepato- 
cyte-stimulating activity have been discovered: leuke- 
mia inhibitory factor [lOI interleukin-1 I [ll] and on- 
costatin M [12]. 
From secondary structure predictions, Bazan [ 133 
proposed that. all these hepatocyte stimulating factors 
together with growth hormone, prolactin, erythropoi- 
etin and granulocyte-colony stimulating factor belong 
to an cc-helical cytokine family. The predicted three- 
dimensional structure of the members of this family is 
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characterized by a bundle of four anti-parallel hclices. 
In addition, two neurotrophic factors, cholinergic dif- 
ferentiation factor, which turned out to be identical with 
LIF [14] and CNTF have also been proposed to be 
members of this r:yrokine family [l S], 
All cytokincs with hepatocyte-stimulating activity 
exert their action via cell-surface receptors consisting of 
at least two subunits. For the receptors of IL-6, LIF and 
OSM a common protein component has been described 
[16]. This protein of a molecular mass of 130 kDa 
(gp130) belongs to the so-called hematopoietic growth 
factor receptor superfamily [17]. Recently it has been 
shown by Ip et al. [18] that gp130 is also a component 
of the CNTF receptor system. Furthermore, it turned 
out from cDNA sequencing of the binding subunit for 
CNTF [19] that this receptor shows 30% amino acid 
identity to the binding subunit of the IL-B-receptor [20]. 
On the basis of the prediction that CNTF belongs to the 
cc-helical cytokine family and the observation that the 
composition of the CNTF-receptor is similar to the re- 
ceptors for the different hepatocyte-stimulating factors, 
we asked the question, whether CNTF has hepatocyte- 
stimulating activiiy. 
Mere we show for the first time that CNTF regulates 
acute-phase protein expression in rat hepatocytes and 
human hepatoma cells. 
2. MATERIALS AND METHOD 
2.1. MlfIrcriul~ 
Human hap@ohin cDNA was il gill of Dr. D. Samols (Cleveland, 
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USA) and buman a,-antichymotrypsin cDNA was supplied by Dr. E. 
Bcrger (Zurich, Switzerland). Rat /3-fibrinogen cDNA was from Dr. 
A. Mitchell (Parkville, Australia). al-macroglobulin cDNA was iso- 
lated as dcscribcd [?I]. Recombinant human (rh)lL-6 was prepared 3s 
described [22]. The specific activity obtained was in the range of I.5 
x 10’ B-cell stimulatory factor 2 LJ/mg protein [23]. RhLIF was the 
generous gift of Dr. N.A. Nicola (Melbourne, Australia). Rat rCNTP 
was obtained from Drs. J. Huber and M. Sendtncr (Martinsried, 
Germany). HepG2 celle stably mnskled with the IL-6 cDNA 
(HepCiZ-IL-6) were established as dcscribLrl [24]. 
2.2. Calf crilrure 
Total RNA ws prepared using the ghcnol extraction method as 
&SWi!W,I’ i!&?Q?j! 5 big fir I&+‘& i?Wi? sinew&& u7C 1% &T&&Yiiw 
ag;lrosc gels and transferred LO CiencScreen plus membranes (Dupont- 
New England Nuclear, Drekich, Germany). The fillers wcrc preliy- 
bridired at WC for 1 h in llI% dexlran su~hle, I PA sodium chluride. 
I% SDS, and hybridized in the same solution \vith cDNA fragments 
labeled by random priming [2Y]. 
2.3. dimlhg lo die sohrblc IL-6 receplor 
Soluble IL-6 receptor W;IS obtained from the conditioned medium 
of NllW3T3 cells transfccted with the gp80-cDNA lacking the sc- 
quenccs coding for the transmcmbrane and cytoplusmic domains [24]. 
The supernalant was incubated for 3 h ut 4°C with [“51]IL-6 in the 
prescncc of an up to 3 I.MlO-fold cxccss of unlabeled cytokines. Solu- 
~JP IL-6 ~esqxor&and so@exss wcpe immunqxss$Wsd whh an 
IL-6 receptor antiserum (T. Stoyan. unpublished results) and protcin- 
A- Supharosc. 
3. RESULTS AND DISCUSSION 
To examine whether CNTF exhibits hepatocyle-stim- 
ulating activity, we incubated human hepatoma cells 
(HepG2) and primary rat hepatocytes in the presence of 
10 @ml CNTF. For comparison cells were stimulated 
with lL-6 and LIF, which are well-documented hepato- 
cyte-stimulating factors [6-lo]. Fig. 1A shows the stim- 
ulation of mRNA expression of the acute-phase pro- 
teins ACT and HPT in HepG2 cells and of a,M and FIB 
in rat primary hepatocytes. While IL-6 treatment led to 
the strongest stimulation, CNTF and LIF induced 
acute-phase protein synthesis to n comparable extent. 
The dose-response of induction of FIB by CNTF 
showed saturation at I @ml. The maximal response 
was reached at 18 b (Fig. 1 B). Comparable time courses 
and dose-responses have been described for IL-G and 
LIF [G,7,10]. 
Since it had been reported that the CNTF receptor is 
homologous to the gpS0 IL-6 receptor [19,20] we asked 
whether the IL-6 receptor is a potential CNTF binding 
protein on liver cells. Fig. 2A shows that neither CNrfF 
nor LIF compeled with [“51]rhIL-6 for binding to the 
soluble IL-6 receptor [24], whereas IL-G at a loo-fold 
excess completely disp:Jced [“sI]rhIL-6. To further 
prove that CNTF does net act via the IL-6 receptor, WC 
made use of the recently established cell line HepG2-IL- 
6 [24]. These cells do not express gpS0 IL-6 receptors on 
the surface and have lost their responsiveness to IL-6 
but not to other cytokines such as LIF or transforming 
growth factor /3 [24]. Incubation of these cells with 
CNTF and LIF, but not with IL-6, led to the induction 
of HPT and ACT mRNA (Fig. 2B) and protein (data 
not shown). These results indicate that CNTF and LIF 
do not bind to the gp80 IL-6 receptor and do not use 
this protein for signalling. 
Since it had been speculated that the binding subunit 
of the LIF receptor is part of the functional CNTF 
P&+$&F &XQJ&Y #-$ Ir #J&V &&LV&&Q &P .tzti ?&&&?A~ 
CNTF exhibited hepatocyte-stimulating activity on the 
human hepatoma cell line Hep3B which has been shown 
not to express the LIF receptor protein [29]. Fig. 3 
shows that CNTF as well as LIF fail to stimulate acute- 
phase protein synthesis in these cells, whereas treatment 
with IL-6 leads to an upregulation of ACT and HPT 
mRNA expression. 
From our experiments we conclude that hepatocytes 
are responsive to CNTF and that the functional hepatic 
CNTF receptor consists of the l&and binding subunit 
of the LIF receptor complex in addition to the CNTP 
binding subunit. In neuronal cells it has been implied 
that gpl30 is a component of the CNTF receptor com- 
plex $181. Since the 5~130 protein is also expressed in 
hepatocytes [30,31], we speculate that it is involved in 
the formation of the functional hepatic CNTF receptor 
complex. 
CNTF is a neurotrophic factor which has been puri- 
fied and cloned from rat sciatic nerve [32,33]. From the 
deduced amino acid sequence it turned out that unlike 
other members of the hemaiopoietic family, CNTF is 
a cytosolic protein without a signal peptide. CNTF is 
present in large quantities in non-neuronal cells of the 
central and peripheral nervous systems. Following cell 
lesion CNTF is locally released and exerts its neurotro- 
phic activity [34,35]. So far it is not clear whether CNTF 
can be secreted under physiological conditions. How- 
ever, the cytokine lL-1 is exported into the bloodstream 
although it contains no signal peptidc f36J. 
The physiological relevance of our finding that 
CNTF upregulates hepatic acute-phase protein synthe- 
sis is not yet clear. There are no data available about 
CNTF production and distribution in body fluids out- 
side the nervous system. Triggering of acute-phase pro- 
tein synthesis by CNTF in the liver however, might 
occur after lesion of peripheral nerves, e.g. as a conse- 
quence of injury, thereby initiating a systemic response 
to the disturbance of homeostasis. 
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Fig. I. EffLxt of CNTF, IL-6 and LIF on acute-phase protein expression in HrpGZ cells and primary rat hepatocytes. (A) Hepatocyte-stili~ulating 
aclivity of CNTF, IL-6 and LIP. After incubation of the cells with 10 n&ml CNTF, 100 U/ml 1L.B or 100 U/ml LIF for IS h, total RNA was 
extracted and subjected to Northern blot analysis. The filters wcrc hybridized with cDNAs coding for human HPT, human ACT, rat FIB, or rat 
azM. (B) Time course and dose-response of FIB induction of primary ral hcpatocytes in response to CNTF. Cells were stimulatd with 10 ng/ml 
CNTF (time course) or for 18 h (dose-response) as indicated in the Rgure. 
‘1t sh.-u,IA hP not& *hsf aCEt+ohncs. a. C..+W.W I_ . . .M.+ . . . . M , -._+_ proteir?s are syr?- 
thesized not only by the liver, but also in cells of the 
choroid plexus [37] and in placenta [38,39]. The regula- 
tion of acute-phase protein synthesis in the latter two 
orgcm is differefit fr’r011-1 tllat of liver. Since CNTF is 
produced in brain, it is possible that it regulates acute- 
phase protein synthesis in choroid plexus cells. A recent 
report shows that CNTF efficiently rescues motor ncu- 
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Fig. 2. Interaction of CNTF, LIP and lL-G with the IL-G receptor (6~80). (A) Cell-f’rcz bindingto lhc soluble IL-6 rcccp~or. Soluble lL-6 rcccptor 
was incubated with [1z51]IL-6 (3x 10” cpm = 3 ng) and increasing amounts (0 to I .OCW’old excess) of unhbelcd cytokincs. The amourn of [i2s1]IL-6 
bound to lhe soluble IL-6 receptor was estimated as described in section 2. (Lt) EtTcct on acute-phase protein cxprcssion in HcpG2-IL-6~41s. After 
incubation of’McpG2-IL-6 cells with IO r@nl CNTF, 100 U/ml IL-G IN 100 U/ml LIF for IS h. to~al HNA was exirackd and subjcctcd to Northern 
blot unalysis. The filters wcrc hybridixd with cDNAs coding Tar human IiPT and human ACT. 
rons from degeneration in progressive motor neurono- 
pathy in mice [40]. This observation may ha:e an 
enormous potential for the treatment of human motor 
neuron diseases. Clinical trials of CNTF with such pa- 
tients are under way [413. In this respect our finding that 
CNTF strongly induces acute-phase protein synthesis in 
hepatocytes of the liver is of great importance. Furlher- 
more, it is possible that CNTF may also act on other 
cells and tissues in the organism such as B-cells and 
T-cells which have been shown to be stimulated by lL-6. 
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Fig. 3. Induction of acute-phase protein expression in HepJB &Is by 
CNTF, LLF and IL-6. Hlp3B cells were incubated for 18 h in the 
presence of 100 U/ml IL-6, 100 U/ml LIF or 10 @ml CNTF. RNA 
extraction and Northern blot analysis were carried out with human 
HPT and ACT cDNAs. 
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